|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.89 CNY | -1.22% |
|
+3.84% | -5.48% |
| 04-26 | Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-19 | Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat | MT |
Yixintang Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 17,380.31 million compared to CNY 17,431.62 million a year ago. Net income was CNY 549.38 million compared to CNY 1,010 million a year ago.
Basic earnings per share from continuing operations was CNY 0.9201 compared to CNY 1.7022 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.48% | 1.81B | |
| -34.16% | 14.83B | |
| -24.55% | 12.04B | |
| -25.24% | 6.52B | |
| +14.96% | 6.44B | |
| -8.01% | 6.15B | |
| -2.77% | 4.64B | |
| +60.00% | 4.62B | |
| -8.10% | 3.93B | |
| -11.16% | 3.49B |
YIXINTANG PHARMACEUTICAL GROUP CO., LTD. 
